Bardacke Julie A, Yarrow Linda, Rosenkranz Sara K
Department of Food, Nutrition, Dietetics and Health, College of Health and Human Sciences, Kansas State University, Manhattan, KS, United States.
Department of Kinesiology and Nutrition Sciences, College of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, United States.
Curr Dev Nutr. 2023 Sep 6;7(10):101997. doi: 10.1016/j.cdnut.2023.101997. eCollection 2023 Oct.
Short-term studies indicate that low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diets (LFDs) can improve symptoms for patients with irritable bowel syndrome (IBS). However, long-term (≥6 mo) effectiveness, safety, and sustainability of an LFD are not well understood and remain controversial. The primary purpose of the current review was to consider the published research on the effectiveness, safety, and sustainability of an LFD for patients with IBS. The secondary aim was to develop an infographic for dissemination to outpatient registered dietitian nutritionists and other healthcare professionals who work with patients with IBS. Three electronic databases (PubMed, Scopus, and Web of Science) were searched through December 2022, using the terms irritable bowel syndrome, FODMAP, and long-term. Following article selection, a total of 14 studies were included. Nine of 9 studies reported significant improvements in symptoms, 7 of 7 studies showed significant improvements in bowel habits, 1 of 1 study showed significantly improved disease course, and 6 of 6 studies showed significantly improved quality of life, compared to baseline. One study showed that improvement in gastrointestinal symptoms was significantly correlated with improvements in quality of life. Two of 3 studies and body composition measures indicated that nutritional adequacy was not compromised. Two of 2 studies showed that gut microbiota did not change, but 1 study showed decreased short-chain fatty acids. Adherence rates ranged from 50% to 82%, and 1 study showed that greater adherence was significantly correlated with improved IBS symptoms. Three of 3 studies showed that better adherence to an LFD was associated with improved symptom relief, and 70%-89% of participants reported satisfaction with the LFD for IBS management. The main difficulties reported were the higher expense and adhering to the diet when eating at restaurants, with family and friends, or while traveling. Overall, a long-term LFD for IBS management can be effective, safe, and sustainable.
短期研究表明,低可发酵寡糖、双糖、单糖和多元醇饮食(LFD)可改善肠易激综合征(IBS)患者的症状。然而,LFD的长期(≥6个月)有效性、安全性和可持续性尚未得到充分了解,仍存在争议。本综述的主要目的是考量已发表的关于LFD对IBS患者有效性、安全性和可持续性的研究。次要目的是制作一份信息图表,分发给门诊注册营养师和其他为IBS患者提供服务的医疗保健专业人员。通过检索三个电子数据库(PubMed、Scopus和Web of Science)至2022年12月,使用了肠易激综合征、FODMAP和长期等检索词。经过文章筛选,共纳入14项研究。与基线相比,9项研究中有9项报告症状有显著改善,7项研究中有7项显示排便习惯有显著改善,1项研究中有1项显示病程显著改善,6项研究中有6项显示生活质量显著改善。一项研究表明,胃肠道症状的改善与生活质量的改善显著相关。3项研究中有2项以及身体成分测量表明营养充足未受影响。2项研究中有2项表明肠道微生物群未发生变化,但1项研究显示短链脂肪酸减少。依从率在50%至82%之间,1项研究表明更高的依从性与IBS症状改善显著相关。3项研究中有3项表明更好地坚持LFD与症状缓解改善相关,70%-89%的参与者报告对用于IBS管理的LFD满意。报告的主要困难是费用较高,以及在与家人、朋友外出就餐、旅行时坚持饮食。总体而言,用于IBS管理的长期LFD可能是有效、安全和可持续的。